Rare skin and muscle disease under the microscope in guadeloupe
NCT ID NCT07265999
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tracks 10 people in Guadeloupe with dermatomyositis, a rare autoimmune disease that affects skin and muscles. Researchers want to see how severe the disease is at diagnosis, including muscle weakness, organ problems, and cancer links. No new treatment is being tested — the goal is simply to learn more about the disease in this population.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand how dermatomyositis affects Caribbean patients and improve care for this group.
- What could go wrong
- This is a very small observational study (10 people) in one region, so findings may not apply to other populations. It does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de la Guadeloupe
RECRUITINGPointe-à-Pitre, 97139, Guadeloupe
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted immune drug calm rare muscle inflammation?
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Can a skin biopsy tell your doctor which treatment will work?
- New hope for rare muscle disease: baricitinib trial aims to cut steroid use
- Scientists probe hidden clot risks in autoimmune skin disorders
- Can an online program help young people with lupus and dermatomyositis feel less stressed?